| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order | 
|---|---|---|---|---|---|---|
| 137751-25MG | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C29H19Cl4O4P | |
| 137742-1G | 
                     | 
                1412439-84-9 | 
                     (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C29H21N2O8P | |
| 137742-100MG | 
                     | 
                1412439-84-9 | 
                     (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C29H21N2O8P | |
| 137742-25MG | 
                     | 
                1412439-84-9 | 
                     (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C29H21N2O8P | |
| 137741-1G | 
                     | 
                1352810-37-7 | 
                     (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C29H21N2O8P | |
| 137741-100MG | 
                     | 
                1352810-37-7 | 
                     (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C29H21N2O8P | |
| 137741-25MG | 
                     | 
                1352810-37-7 | 
                     (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C29H21N2O8P | |
| 137732-1G | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C31H27O6P | |
| 137732-100MG | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C31H27O6P | |
| 137732-25MG | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C31H27O6P | |
| 137731-1G | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C31H27O6P | |
| 137731-100MG | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C31H27O6P | |
| 137731-25MG | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C31H27O6P | |
| 137722-1G | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C31H21F6O4P | |
| 137722-100MG | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C31H21F6O4P | |
| 137722-25MG | 
                     | 
                NA | 
                     (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C31H21F6O4P | |
| 137721-1G | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C31H21F6O4P | |
| 137721-100MG | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C31H21F6O4P | |
| 137721-25MG | 
                     | 
                NA | 
                     (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C31H21F6O4P | |
| 134908-1G | 
                     | 
                NA | 
                     (11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C37H39O4P | |